As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …

HIV infection has transitioned from an acute, fatal disease to a chronic one managed by
antiretroviral therapy. Thus, the aging population of people living with HIV (PLWH) continues …

Background The risk of cardiovascular disease is increased among persons with human
immunodeficiency virus (HIV) infection, so data regarding primary prevention strategies in …

Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

Antiretroviral therapy has largely transformed HIV infection into a chronic disease condition.
As such, physicians and other providers caring for individuals living with HIV infection need …

Abstract Purpose of Review This review will outline the multilevel effects of biological sex on
HIV acquisition, pathogenesis, treatment response, and prospects for cure. Potential …

Although white AT can contribute to anti-infectious immune responses, it can also be
targeted and perturbed by pathogens. The AT's immune involvement is primarily due to …

Background Cardiovascular disease (CVD) is more frequent among people with HIV (PWH)
and may relate to traditional and nontraditional factors, including inflammation and immune …

Abstract The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or
statins, are administered as first line therapy for hypercholesterolemia, both in primary and …

Polypharmacy is a growing problem and mechanisms of injury likely include potentially
inappropriate medications, total drug burden, known pairwise drug interactions, higher level …